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Backgrounds: Patients with diabetes mellitus (DM) have higher mortality and morbidity despite intense lipid lowering therapy. The underlying 
pathophysiology is not well understood.
objectives: We compared the changes in plaque characteristics in response to statin therapy between DM and non-DM patients using optical 
coherence tomography (OCT)
methods: Fibrous cap thickness (FCT) in non-culprit lipid plaque was measured at baseline, 6 months, and 12 months in 22 DM and 20 non-DM 
patients. Blood samples for lipid and hs-CRP were drawn at each time point.
results: Fibrous cap became thicker with lipid lowering therapy in both DM patients (from 65.2 ± 15.6 μm at baseline to 81.1 ± 22.3 μm at 6 
months to 101.4 ± 30.6 μm at 12 months, all p < 0.01) and Non-DM patients (from 58.9 ± 14.0 μm at baseline to 89.1 ± 25.1 μm at 6 months to 
118 ± 44.5 μm at 12 months, all p < 0.01). However, the percent change in FCT in non-DM patient was significantly greater than in DM patient both 
at 6-months and 12-months (Figure). The change in low density lipoprotein cholesterol level and the change in hs-CRP were both similar between 
the DM patients and non-DM subjects at 6 months, and 12 months.
conclusions: Despite equivalent improvement of laboratory values, plaque stabilization was significantly attenuated in DM patients.
 
